AIM
DGX icon

abrdn Investment Management’s Quest Diagnostics DGX Stock Holding History

abrdn Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,038
Closed -$366K – 517
2014
Q3 		$366K Sell
6,038
-96
-2% -$5.92K ﹤0.01% 502
2014
Q2 		$360K Sell
6,134
-252
-4% -$14.8K ﹤0.01% 487
2014
Q1 		$370K Sell
6,386
-22
-0.3% -$1.18K ﹤0.01% 411
2013
Q4 		$343K Sell
6,408
-119
-2% -$7.06K ﹤0.01% 444
2013
Q3 		$403K Sell
6,527
-312
-5% -$18.7K ﹤0.01% 418
2013
Q2 		$415K Buy
+6,839
New +$407K ﹤0.01% 386

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

abrdn Investment Management's DGX Position: Q4 2014 in Review

abrdn Investment Management sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 6,038 shares — an estimated $366K sold.

abrdn Investment Management first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $415K in Q2 2013. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • abrdn Investment Management reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • abrdn Investment Management sold 6,038 Quest Diagnostics shares in Q4 2014, an estimated $366K.
  • abrdn Investment Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
  • abrdn Investment Management's Quest Diagnostics position peaked at $415K in Q2 2013.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on abrdn Investment Management's 13F filing for Q4 2014, filed 13 Feb 2015.